Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05319509
Other study ID # HSC-SPH-21-0935
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2022
Est. completion date August 1, 2027

Study information

Verified date May 2024
Source The University of Texas Health Science Center, Houston
Contact Tsai Jack, PhD
Phone 210-276-9022
Email Jack.Tsai@uth.tmc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess changes in self-reported anxiety over the course of six virtual reality (VR) sessions and to assess changes in academic self-efficacy, as well as examine the feasibility and acceptability of a relatively short and time intensive VR intervention (i.e.,six sessions over the course of three weeks) for reducing anxiety symptoms in college students.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date August 1, 2027
Est. primary completion date April 1, 2027
Accepts healthy volunteers No
Gender All
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - enrolled in The University of Texas Health Science Center School of Public Health San Antonio regional campus - competent in English - total score of at least 3 on the Generalized Anxiety Disorder (GAD-2) Exclusion Criteria: - Currently receiving psychological treatment for anxiety symptoms, or has received treatment in the last year. - Report photosensitive epilepsy. - Report stereoscopic vision or balance problems

Study Design


Related Conditions & MeSH terms


Intervention

Device:
gameChange
Staff will explain the rationale behind gameChange, and briefly explain the different scenarios: a doctor's office, a waiting room, a pub, a café, a grocery store, a public street and a bus. Each scenario contains five levels, each increasing with anxiety stimuli and certain tasks the participant must complete. The participant will put on the Oculus headset, and go through a preliminary orientation game. The headset will be casted to an external monitor. Once they start gameChange, it will take the participants to the virtual therapist's room. They will be asked to choose which scenario they would like to participate in first and will complete all five levels for one scenario. Research staff will be taking event sampling-style observations of the participant. After completion of the levels, the participant will return to the virtual therapist's room for debriefing, and then will be asked to exit the game.

Locations

Country Name City State
United States The University of Texas Health Science Center at Houston Houston Texas

Sponsors (1)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in state anxiety as assessed by the Liebowitz Social Anxiety Scale-Self Report version (LSAS-SR) The LSAS-SR questionnaire is composed of 24 items divided into 2 subscales, 13 concerning performance anxiety, and 11 pertaining to social situations. The 24 items are first rated on a Likert Scale from 0(none) to 3(severe) on fear felt during the situations, and then the same items are rated from 0(never)-3(usually)regarding avoidance of the situation. Combining the total scores for the Fear and Avoidance sections provides an overall score with a maximum of 144 points. Score of 30 or less indicates social anxiety disorder(SAD) is unlikely, score of 30-60 shows that SAD is probable and score 60-90 indicates that SAD is highly probable. before first session in week 1, before third session in week 2 and before sixth session in week 3
Primary Change in depressive symptoms as assessed by score on the Patient Health Questionnaire-4 (PHQ-4) The PHQ-4 questionnaire consists of 4 questions and each is rated on a 4 point scale from 0(not at all) to 3(every day) for a maximum score of 12,a higher number indicating a worse outcome. Baseline(before the first session in week 1)
Primary Change in anxiety related behaviors such as rate of speech Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in anxiety related behaviors such as volume of speech Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in anxiety related behaviors such as Negative self-talk Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in anxiety related behaviors such as Utterances about experience Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in anxiety related behaviors such as Laughter Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in Psychomotor agitation such as pacing Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in Psychomotor agitation such as Fidgeting Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in Psychomotor agitation such as Rubbing hands/neck/head Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Primary Change in physiology such as perspiration Anxiety-related behaviors will be recorded using an event sampling observation guide Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)
Secondary Change in self-reported academic performance as assessed by the Motivated Strategies for Learning Questionnaire (MSLQ) The MSLQ questionnaire consists of 9 questions each one is scored from 1= not at all true of me to 7=very true of me, a higher number indicating a better outcome with a maximum score of 63 before first session in week 1, before third session in week 2 and before sixth session in week 3
Secondary change in feasibility as assessed by the rating on a short questionnaire The usability questionnaire is developed by gameChange about the ease of VR software use, believability of VR environment, and level of engagement. this consists of 5 questions and each one is scored form 1(very difficult) to 5(very easy) for a maximum score of 25, a higher number indicating more easiness in using the VR software after the third session in week 2 , after sixth session in week 3
Secondary Change in acceptability as assessed by the rating on a short questionnaire The usability questionnaire is developed by gameChange about the ease of VR software use, believability of VR environment, and level of engagement. this consists of 5 questions and each is scored form 1(strongly disagree) to 5(strongly agree) for a maximum score of 25 after the third session in week 2 , after sixth session in week 3
Secondary Change in perceived presence in the virtual environment (as indicated by continuous score on the Igroup Presence Questionnaire (IPQ) There are 14 questions and each one is scored form -3 to +3. A total negative score indicates that the participant personally felt very disconnected from VR world, and that they lacked believable presence within world, and rather felt like they were manipulating a machine from an outside perspective. after the third session in week 2 and the sixth session in week 3
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04579354 - Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia N/A
Completed NCT03535805 - Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting NCT05302167 - Molehill Mountain Feasibility Study. N/A
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Completed NCT05881681 - A Mindfulness Approach to UA for Afro-descendants N/A
Active, not recruiting NCT04961112 - Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits N/A
Terminated NCT04612491 - Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
Completed NCT05980845 - The Effect Nature Sounds and Music on Hemodialysis Patients N/A
Recruiting NCT05449002 - Digital Single Session Intervention for Youth Mental Health N/A
Completed NCT05585749 - Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients N/A
Terminated NCT03272555 - WILD 5 Wellness: A 30-Day Intervention N/A
Recruiting NCT05997849 - Development of a Multiplatform Mental Health Mobile Tool N/A
Completed NCT06421233 - The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels N/A